Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
NNNN: Anbio Biotechnology Class A Ordinary Shares Stock Analysis | finqOS
Healthcare · Medical - Instruments & Supplies
The Story
NNNN
The Story
NNNN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+21.9% / yr
Operating margin
65.2%
ROIC
25.5%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
344.31×
Valuation
Unrated
P/E ratio
51.2×
Anbio Biotechnology Class A Ordinary Shares
NNNN
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Anbio Biotechnology Class A Ordinary Shares
NNNN
NASDAQ
·
USD
·
Closed
$9.90
−7.91%
$9.90
−$0.85 (7.91%)
52W Range
3th
pctl
Volume
0.91×
avg
Mkt Cap
434.52M
USD
P/E
51.2
TTM
Div Yield
–
ann
52W Range
3th
pctl
Volume
0.91×
avg
Market Cap
434.52M
USD
P/E Ratio
51.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings